苯甲酰苯乙酸 | 32530-22-6

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 苯甲酰苯乙酸
• 英文名称: 3-oxo-2,3-diphenylpropanoic acid
• 英文别名: benzoylphenylacetic acid；Phenylbenzoylessigsaure
• CAS: 32530-22-6
• 化学式: C₁₅H₁₂O₃
• 分子量: 240.258
• InChiKey: YVKSMFUEDUPYIF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  苯甲酰苯乙酸 在 五氟苯硼酸 、 草酸 作用下， 以 硝基甲烷 为溶剂， 反应 24.0h， 生成 二苯基乙酮
  参考文献：
  名称：

  芳基硼酸催化的β-酮酸和醇的脱水单/二烷基化反应

  摘要：

  醇和β-酮酸的脱水单/二烷基化反应在芳基硼酸催化下实现，以15-99％的收率提供一系列β-芳基酮和β-酮​​酯，副产物CO 2和H 2 O . 在这种情况下，脱羧烷基化反应在 50°C 时发生生成 β-芳基酮，而在 0°C 时脱羧被抑制生成二烷基酯产物。基于对照实验提出了一种可能的催化循环。

  DOI：

  10.1021/acs.orglett.1c04050
• 作为产物：
  描述：

  keto(diphenylpropenone) 在 水 作用下， 生成 苯甲酰苯乙酸
  参考文献：
  名称：

  Durch sterische effekte stabilisierteß-ketocarbonsäuren

  摘要：

  β-酮基羧酸的空间位阻增加，导致脱羧的动力学稳定性增加，直至达到在室温下完全稳定的体系。同时，改变互变异构平衡以有利于（Z）-烯醇，最后有利于（E）-构型的烯醇。

  DOI：

  10.1016/s0040-4039(01)93755-4

文献信息

• POLYMORPHS OF BROMFENAC SODIUM AND METHODS FOR PREPARING BROMFENAC SODIUM POLYMORPHS
  申请人：Matharu Saroop Singh

  公开号：US20110092596A1

  公开（公告）日：2011-04-21

  Different polymorphs of bromfenac sodium may be prepared and interconverted using crystallization/recrystallization, drying and/or hydration techniques.

  溴芬酸钠的不同多晶形态可以通过结晶/重结晶、干燥和/或水合技术进行制备和相互转换。
• CRTH2 Receptor Ligands For Medicinal Uses
  申请人：Ulven Trond

  公开号：US20090099189A1

  公开（公告）日：2009-04-16

  Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis, wherein A represents a carboxyl group —COON, or a carboxyl bioisostere; A 1 , is hydrogen or methyl; ring Ar 1 is an optionally substituted phenyl ring 5- or 6-membered monocyclic heteroaryl ring, in which AA 1 CHO— and L2 are linked to adjacent ring atoms; rings Are 2 , Ar 3 each independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; t is 0 or 1; L2 and L3 are linker radicals as defined in the description.

  式(I)的化合物可用于治疗对CRTH2受体活性调节敏感的疾病，例如哮喘、鼻炎、过敏性气道综合症和过敏性鼻支气管炎，其中A代表羧基—COON或羧基生物同位素；A1为氢或甲基；环Ar1是一个可选取代的苯环5-或6-成员的单环杂环，其中AA1CHO—和L2与相邻的环原子连接；环Are2，Ar3各自独立地表示一个苯环或5-或6-成员的单环杂环，或由一个5-或6-成员的碳环或杂环组成的双环系统，该环或环系统被苯并或与一个5-或6-成员的单环杂环融合，该环或环系统是可选取代的；t为0或1；L2和L3是如描述中所定义的连接基团。
• Compounds As Ccri Antagonists
  申请人：Heng Richard

  公开号：US20070196270A1

  公开（公告）日：2007-08-23

  A compound of formula I, or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is implicated, e.g. inflammatory diseases.

  化合物I的公式，或其药学上可接受的盐或酯，其中符号的含义如定义的那样，它们是CCR-1的拮抗剂，并且在药学上用于治疗与CCR-1有关的疾病和症状，例如炎症性疾病。
• Oxadiazole Derivatives with Crth2 Receptor Activity
  申请人：Receveur Jean-Marie

  公开号：US20080312220A1

  公开（公告）日：2008-12-18

  Compounds of formula are CRTH2 ligands, useful for treatment of inflammatory, autoimmune, respiratory or allergy disease: wherein R 1 is hydrogen or methyl and R 2 is optionally substituted cycloalkyl, or optionally substituted non-aromatic heterocyclyl having to 6 ring atoms; or R 1 and R 2 , taken together with the carbon atom to which they are attached form an optionally substituted cycloalkyl, or optionally substituted non-aromatic heterocyclyl having 4 to 6 ring atoms: or R 1 and R 2 , taken together with the carbon atom to which they are attached form an optionally substituted cycloalkyl, or optionally substituted cycloalkyl, or optionally substituted non-aromatic heterocyclyl ring having 4 to 6 ring atoms; R is hydrogen or an optional substitutent by 1, 2 or 3 optional substituents; A is hydrogen or C 1 -C 3 alkyl; and ring Ar is an optionally substituted phenyl or 5- or 6-membered monocyclic heteroaryl ring.

  该化合物的分子式为CRTH2配体，可用于治疗炎症、自身免疫、呼吸或过敏性疾病：其中R1为氢或甲基，R2为可选取代的环烷基，或具有1-6个环原子的可选取代的非芳香杂环基；或R1和R2与它们所附着的碳原子一起形成一个可选取代的环烷基，或具有4-6个环原子的可选取代的非芳香杂环基；或R1和R2与它们所附着的碳原子一起形成一个可选取代的环烷基，或可选取代的环烷基，或具有4-6个环原子的可选取代的非芳香杂环基环；R为氢或1、2或3个可选取代基团；A为氢或C1-C3烷基；环Ar为可选取代的苯基或5-或6-成员单环杂芳基环。
• CRTH2 receptor ligands for medicinal uses
  申请人：Ulven Trond

  公开号：US20110269763A1

  公开（公告）日：2011-11-03

  Compounds of formula (I) are useful for the treatment of disease responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis: wherein A represents a carboxyl group —COOH, or a carboxyl bioisostere; A 1 is hydrogen or methyl; ring Ar 1 is an optionally substituted phenyl ring or 5- or 6-membered monocyclic heteroaryl ring, in which AA 1 CHO— and L2 are linked to adjacent ring atoms; rings Ar 2 , Ar 3 each independently represent a phenyl or 5- or 6-membered monocyclic heteroaryl ring, or a bicyclic ring system consisting of a 5- or 6-membered carbocyclic or heterocyclic ring which is benz-fused or fused to a 5- or 6-membered monocyclic heteroaryl ring, said ring or ring system being optionally substituted; t is 0 or 1; L2 and L3 are linker radicals as defined in the description.

  式(I)的化合物可用于治疗对CRTH2受体活性调节敏感的疾病，例如哮喘、鼻炎、过敏性气道综合症和过敏性鼻支气管炎：其中A代表羧基—COOH或羧基生物同位素；A1为氢或甲基；环Ar1为可选取代的苯环或5-或6-成员的单环杂环，其中AA1CHO—和L2连接到相邻的环原子上；环Ar2、Ar3各自独立地表示苯环或5-或6-成员的单环杂环，或由5-或6-成员的碳环或杂环组成的双环系统，该环或环系统是苯并或与5-或6-成员的单环杂环融合，该环或环系统是可选的取代；t为0或1；L2和L3是如描述中定义的连接基。